<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00119</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Surveillance <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Establish mechanism(s) to provide clinicians with appropriate laboratory tests for the diagnosis of Legionnaires' disease. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 339,367,368,372,654 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Conduct active search for cases of nosocomial Legionnaires' disease, especially in patients who are at high-risk of acquiring the disease (patients who are immunosuppressed, including organ-transplant patients, patients with AIDS, and patients receiving systemic steroids; are "65 years of age; or have chronic underlying disease such as diabetes mellitus, congestive heart failure, and chronic obstructive lung disease). <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 338,339,353,355&hyph;359,365 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Refer to the accompanying background document for definition of nosocomial legionellosis. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> NO RECOMMENDATION <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  for routinely culturing water systems for  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Legionella <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 250,338,383,387&hyph;389,391&hyph;393,408,655 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> UNRESOLVED ISSUE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Interruption of Transmission of Legionella SPP. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Primary Prevention (Preventing Nosocomial Legionnaires' Disease When No Cases Have Been Documented) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Nebulization and Other Devices <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> a. Use only sterile (not distilled, nonsterile) water for rinsing nebulization devices and other respiratory-care equipment after they have been cleaned and/or disinfected. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 250,656 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> b. Use only sterile (not distilled, nonsterile) water to fill reservoirs of devices used for nebulization. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 227,236,250,378,656 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> c. Do not use large-volume room-air humidifiers that create aerosols (e.g., by venturi principle, ultrasound, or spinning disk) and thus are really nebulizers, unless they can be sterilized or subjected to high-level disinfection daily and filled only with sterile water. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 236,656 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Cooling Towers <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> a. When a new hospital building is constructed, place cooling tower(s) in such a way that the tower drift is directed away from the hospital's air-intake system, and design the cooling towers such that the volume of aerosol drift is minimized. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 375,657 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> b. For operational cooling towers, install drift eliminators, regularly use an effective biocide, maintain the tower according to manufacturers' recommendations, and keep adequate maintenance records. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 375,415,658 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Water-Distribution System <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> a.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> NO RECOMMENDATION <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  for routinely maintaining potable water at the outlet at "50 <!-- PJG 0017 degreeslatlong --> &cir;C or &lt;20 <!-- PJG 0017 degreeslatlong --> &cir;C, or chlorinating heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 338,383,393,400&hyph;403 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> UNRESOLVED ISSUE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> b.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> NO RECOMMENDATION <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  for treatment of water with ozone, ultraviolet light, or heavy-metal ions. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=2 f=1 --> 344,411,412,414 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> UNRESOLVED ISSUE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Secondary Prevention (Response to Identification of Laboratory-Confirmed Nosocomial Legionellosis) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> When a single case of laboratory-confirmed, definite nosocomial Legionnaires' disease is identified, OR if two or more cases of laboratory-confirmed, possible nosocomial Legionnaires' disease occur within 6 months of each other (Refer to background document for definition of definite and possible nosocomial Legionnaires' disease.): <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Contact the local or state health department or the CDC for consultation. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. If a case is identified in a severely immunocompromised patient such as an organ-transplant recipient, OR if the hospital houses severely immunocompromised patients, conduct a combined epidemiologic and environmental investigation (as outlined from II&hyph;B&hyph;3&hyph;b&hyph;1 through II&hyph;B&hyph;5, below) to determine the source(s) of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Legionella <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  sp. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3. If the hospital does not house severely immunocompromised patients, conduct an epidemiologic investigation via a retrospective review of microbiologic, serologic, and postmortem data, and an intensive prospective surveillance for additional cases of nosocomial Legionnaires' disease. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            